Trial intelligence / Profile preview

Minocycline for wound healing and peri-implant microbiota after implant surgery

ChiCTR2100044680Phase 4Recruiting

Sponsor
Sichuan University West China Hospital of Stomatology
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of minocycline in peri-implant disease (2 arms), sponsored by Sichuan University West China Hospital of Stomatology. Primary endpoints: Landry Wound-Healing Index (WHI), Inflammatory factor levels and 1 more. Started Mar 2021; status: recruiting.

02

Drugs

minocycline
03

Conditions

peri-implant disease

Beyond the preview

Go deeper on ChiCTR2100044680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call